Halper Sadeh LLC said it is investigating nine proposed acquisitions for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The matters involve Option Care Health's sale to CD&R and McKesson for $32.05 per share; PTC's sale to Schneider Electric for $205.00 per share in cash; RXO's sale to C.H. Robinson for $17.25 in cash plus 0.0856 C.H. Robinson shares per RXO share; Baldwin Group's sale to Sequence Holdings and DFO Management for $32.50 in cash per share; Lifecore Biomedical's sale to Webster Equity Partners for $6.28 in cash plus one non-tradable contingent value right per share; Pacira BioSciences' sale to Viatris for $36.50 in cash; Synaptics' sale to onsemi for $123.00 per share in cash; Capital Bancorp's sale to Peoples Bancorp for 1.11 Peoples shares per Capital share; and SoundThinking's sale to Transom Capital Group for $8.00 per share in cash plus one non-transferable contingent value right worth up to $3.00 per share. The firm said the transactions may provide substantial benefits to insiders unavailable to ordinary shareholders and may contain terms restricting superior competing offers. Halper Sadeh said it may seek increased consideration, additional disclosures and information, or other relief and benefits, and invited shareholders to discuss their rights and options at no cost or obligation. Legal fees and expenses would be handled on a contingent-fee basis, with clients not responsible for out-of-pocket payments.